Q2
BAX — Q2 2026 Financial Report Analysis
Baxter grew Q2 2026 sales 5% to $2.96B and continuing-operations EPS to $0.26, but adjusted EPS fell 5% to $0.56 (including a $0.11 tariff refund) as adjusted gross margin dropped 2.1 points; full-year guidance was raised.